Abstract
Injection of interleukin-1 (IL-1) into pylorus-ligated rats has been shown strongly to inhibit gastric secretion. However, in the present study, we found that an intraperitoneal injection of IL-1 into intact (non-pylorus-ligated) fasted mice rapidly (within 30 min) induced an accumulation of gastric acid (`early response'). When the dose of IL-1 was larger, the accumulation lasted for a longer period.
Injection of IL-1 also caused a later elevation of the activity of histidine decarboxylase (HDC), the histamine-forming enzyme, in the stomach (`later response').
Cimetidine, an antagonist of histamine H2-receptors, suppressed the accumulation of gastric acid in both the early and later periods. An irreversible inhibitor of HDC, α-fluoromethylhistidine, partially inhibited the accumulation in the later period.
IL-1, when injected 1 h after feeding in mice fasted overnight, markedly retarded gastric emptying.
Tumour necrosis factor (TNF) and lipopolysaccharide (LPS) or endotoxin from E. coli both had IL-1-like effects on the stomach, and their effects are presumably mediated by IL-1.
These results support the idea that an inhibition of gastric emptying and an elevation of HDC activity in the stomach may explain the findings that a long-lasting accumulation of gastric acid is induced by IL-1 despite its potent inhibition of gastric acid secretion.
On the basis of these results, and in the light of the known actions of histamine, the possible roles of IL-1 in gastric inflammation and ulceration are discussed.
Keywords: Gastric acid, interleukin-1, histamine, histidine decarboxylase, lipopolysaccharide
Full Text
The Full Text of this article is available as a PDF (277.6 KB).